MyAverix Finance
SHE · Healthcare
Wuhan Hiteck Biological Pharma Co Ltd (300683)
Drug Manufacturers - Specialty & Generic
Wuhan Hiteck Biological Pharma Co Ltd (300683) is listed on SHE in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-28, reported market cap is $5.02B, P/E ratio is 18.00, net margin is -30.3%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 300683
Wuhan Hiteck Biological Pharma Co Ltd (300683) — FAQ
What is Wuhan Hiteck Biological Pharma Co Ltd's market cap?
Wuhan Hiteck Biological Pharma Co Ltd (300683) has a reported market cap of $5.02B (data as of 2026-03-28).
What is 300683's P/E ratio?
The price-to-earnings (P/E) ratio for Wuhan Hiteck Biological Pharma Co Ltd (300683) is 18.00 (data as of 2026-03-28).
Does Wuhan Hiteck Biological Pharma Co Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Wuhan Hiteck Biological Pharma Co Ltd (300683). Check the MyAverix Finance app for the latest dividend data.
What sector is Wuhan Hiteck Biological Pharma Co Ltd in?
Wuhan Hiteck Biological Pharma Co Ltd (300683) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is 300683 listed on?
300683 is listed on SHE.
What is Wuhan Hiteck Biological Pharma Co Ltd's net margin?
Wuhan Hiteck Biological Pharma Co Ltd (300683) reports a net margin of -30.3% (data as of 2026-03-28).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.